Payers part of the drug-pricing problem, says FDA commissionerMarch 7, 2018Business of MedicineGene Therapy
States strive to curb costs for a crucial – but exorbitant – hemophilia treatmentMarch 7, 2018Bleeding DisordersBusiness of Medicine
Never too late to operate? Surgery near end of life is common, costlyMarch 1, 2018Business of Medicine
Evaluations of Medicaid experiments by states, CMS are weak, GAO saysFebruary 23, 2018Business of Medicine
Trump administration proposes rule to loosen curbs on short-term health plansFebruary 20, 2018Business of Medicine
